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The Nucleoporin CAN/Nup214 Binds to both the Cytoplasmic
and the Nucleoplasmic Sides of the Nuclear Pore
Complex in Overexpressing Cells
J u d i th  M. B oer,*  J a n  M. A. v an  D eursen ,*  H uib J . C ro e s ,!  J a c k  A. M. F ra n s e n ,!
and Gerard C. Grosveld*’1
*Department of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105; and  tDepartment o f Cell Biology and
Histology, Faculty of Medical Sciences, Catholic University Nijmegen, Nijmegen, The Netherlands
CAN/Nup214, an essential com ponent of the verte­
b ra te  nuclear pore complex (NPC), is requ ired  for 
proper cell cycle progression and  nucleocytoplasmic 
transport. I t is a m em ber of the  FG-repeat-containing 
family of nucleoporins and has been localized to the  
cytoplasmic face of the NPC. Ind irec t immunofluores­
cence studies w ith specific antibodies have shown th a t 
m oderate overexpression of hum an CAN in  HeLa cells 
causes an increase in  CAN/Nup214 levels a t the nuclear 
envelope. Here, we dem onstrate th a t in  such HeLa 
cells, CAN/Nup214 does no t localize exclusively to the 
cytoplasmic side of the  NPC. Cryosections, stained 
w ith CAN-specific antibodies and  exam ined by elec­
tron  microscopy, showed th a t about one-third of the 
gold-labeled NPCs were decorated  a t the  cytoplasmic 
face and the rem aining tw o-thirds a t the nucleoplas­
mic face. These data  indicate th a t both the  cytoplasmic 
fibrils and the nuclear basket of the vertebrate  NPC 
contain specific binding sites for e ither CAN/Nup214 
or for its in teracting  proteins, Nup88 and hCRMl. 
Thus, it  is conceivable th a t CAN/Nup214 functions in  
nucleocytoplasmic tran spo rt a t bo th  faces of the  NPC.
© 1997 Academic Press
INTRODUCTION
The vertebrate nuclear pore complex (NPC), an ~125 
MDa multiprotein assembly that mediates bidirec­
tional transport between the cytoplasm and the nu­
cleus, is composed of a spoke complex embracing a cen­
tral channel or transporter, A cytoplasmic ring with 
filaments emanating into the cytoplasm is attached to
•^To whom correspondence and reprint requests should be ad­
dressed at Department of Genetics, St. Jude Children’s Research 
Hospital, 332 N. Lauderdale, Memphis, TN 38105. Fax: (901) 526- 
2907.
the spoke complex, as is a nuclear ring with filaments 
that converge to form the nuclear basket [for reviews 
see 1, 2]. The NPC consists of multiple copies of an 
estimated 100 different proteins (nucleoporins), includ­
ing integral membrane proteins and peripheral pro­
teins. A number of these nucleoporins contain multiple 
degenerate peptide motifs that share an FG dipeptide 
core sequence [reviewed by 1, 3-5].
Protein import into the nucleus is mediated by a 
heterodimer comprising the nuclear localization sig­
nal (NLS)-receptor/importin a, which recognizes the 
NLSs of karyophilic proteins, and nuclear import fac­
tor p97/importin /?, which contacts the NPC [re­
viewed by 6; see also 7-9], After this first docking 
step, the ligand complex is imported via an energy- 
dependent process tha t requires the small GTPase 
Ran/TC4 [10,11]. GTP hydrolysis by Ran is though to 
drive the translocation reaction [12-14], which may 
involve repeated association and dissociation of im­
port complex components to the NPC [15, 16], or the 
movement of a single complex across the NPC either 
in discrete steps [17] or in a sliding motion [9]. Many 
FG-repeat-containing nucleoporins are located at 
distinct positions along the NPC and may form bind­
ing sites for transport complexes [15, 18, 19]. Protein 
and ribonucleoprotein (RNP) export from the nucleus 
is also a receptor-mediated, energy-dependent pro­
cess [for reviews see 8, 20], and involves some of the 
same factors necessary for protein import [17].
The FG-repeat-containing nucleoporin CAN, also 
called Nup214 and p250, is detected exclusively at the 
cytoplasmic face of the NPC in HeLa cells [21]. InXeno- 
pus  oocytes CAN was sublocalized to the cytoplasmic 
filaments of the NPC [22], Recently, we made a knock­
out mutation of the mouse CAN  gene. Mouse embryos 
that lack CAN show growth arrest, followed by simulta­
neous defects in polyadenylated RNA export and pro­
tein import [23]. Further, coimmunoprecipitation ex­
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periments demonstrated that CAN is part of a complex 
with at least two other polypeptides—one of 88 kDa 
and the other of 112 kDa [24]. Recently, these proteins 
were identified as the novel NPC component Nup88 
and hCRMl, a homolog of yeast CRM1 that is localized 
to the NPC and nucleoplasm [25].
In previous studies, we found that overexpression of 
CAN in HeLa-derived cells results in an increase of 
this nucleoporin at the nuclear envelope [26]. To exam­
ine the sublocalization of overexpressed CAN within 
the NPC, we have used ultrathin cryosections in combi­
nation with immunogold labeling techniques.
MATERIALS AND METHODS
Immunoelectron microscopy. HeLa-derived cell line CE490S has 
been described previously [26], Cells were grown in the presence or 
in the absence of 1 /ig/ml tetracycline, fixed with 2% paraformalde­
hyde in bicarbonate buffer (pH 7.4) for 90 min at room temperature, 
and stored in 1% paraformaldehyde in phosphate buffer (pH 7.3) at 
4°C. Cells were scraped from the dish and pelleted in 10% gelatin. 
Ultrathin cryosectioning and immunolabeling were performed as de­
scribed before [27]. Sections (—100 nm) were incubated with poly­
clonal aCNN antiserum [26], followed by protein A complexed to 10- 
nm gold particles, before being examined and photographed by using 
a JEOL JEM1010 electron microscope, operating at 80 kV.
RESULTS
CE490S cells can be induced to overexpress CAN be­
cause they contain the CAN  cDNA, under the control 
of the tet~operator promoter [26, 28]. In the presence of 
1 /ig/ml tetracycline, CE490S cells express endogenous 
levels of CAN. However, if tetracycline is removed from 
the medium, CAN is moderately overexpressed, with­
out detectably affecting cell growth or nuclear envelope 
structure. Indirect immunofluorescence studies using 
our polyclonal aCNN antiserum, which is directed 
against unique sequences in the N-terminus of CAN, 
showed that the protein is located mainly at the nuclear 
envelope in cells expressing normal CAN levels and in 
cells overexpressing CAN [26],
For ultrastructural localization studies, ultrathin 
cryosections of CE490S cells were first incubated with 
aCNN, followed by protein A complexed to 10-nm gold 
particles. In CAN-overexpressing cells, gold particles 
decorated both cytoplasmic and nucleoplasmic sides of 
the NPCs (Fig. .1). No significant label was found in the 
cytoplasm or nucleoplasm, indicating that the overex­
pressed protein'specifically associated with the NPCs. 
Quantitation of the gold distribution in 100 nuclei 
showed that 59% of the NPCs were decorated at the 
nucleoplasmic side (Fig. IB), 36% at the cytoplasmic 
side (data not shown), and 5% at both sides or in the 
middle (Fig. 1A). The amount of label detected at both 
sides of the NPCs varied, which is probably due to the 
plane of section. Our antibody did not detect gold label
in CE490S cells expressing endogenous levels of CAN 
(data not shown).
DISCUSSION
Our immunoelectron microscopic studies on CAN- 
overexpressing HeLa cells showed that CAN localized 
to both the cytoplasmic and the nucleoplasmic sides of 
the NPC. This result indicates that specific binding 
sites for CAN, or for its interacting proteins, exist on 
both faces of the nuclear pore. The NPCs of normal 
HeLa cells did not stain, which demonstrates that im­
munoelectron detection of CAN with our antiserum, 
directed against N-terminal CAN sequences, requires 
elevated levels of the protein. In previous immunolocal- 
ization studies CAN is detected only at the cytoplasmic 
face of NPCs of normal HeLa cells and Xenopus oocytes 
[21, 22], Why is CAN found at the nucleoplasmic side 
of the NPC in overexpressing HeLa cells?
Studies on normal HeLa cells employed a specific 
antibody against C-terminal CAN sequences, which lo­
calized CAN to the cytoplasmic face of NPCs [21]. It is 
conceivable that epitopes in the C-terminal part of CAN 
are masked specifically at the nucleoplasmic side of the 
NPC. This region may for instance interact with certain 
proteins or protein complexes in the nucleus, thereby 
preventing antibody binding. On the other hand, the 
levels of endogenous CAN at the nucleoplasmic side 
may be too low to detect with the C-terminal CAN anti­
serum.
CAN has also been detected at the cytoplasmic fibrils 
of Xenopus oocyte NPCs with antibodies directed against 
the entire protein [22]. Interestingly, the FG-repeat-con- 
taining nucleoporin p62 is found exclusively at the nu­
cleoplasmic face of NPCs of Xenopus oocyte nuclear enve­
lopes [2, 29]; however, in mammalian liver cells, this pro­
tein localizes to both sides of the NPC [29, 30]. 
Consequently, the sublocalization of nucleoporins at the 
NPC may vary with cell-type or with the expression level 
of the nucleoporin.
Altered expression levels of nucleoporins may poten­
tially disrupt the normal distribution or architecture of 
the NPCs. However, our electron micrographs showed no 
gross alterations of nuclear envelope structure, such as 
herniations or NPC clustering [see, e.g., 31, 32]. More­
over, the growth rate of CE490S cells was not affected, 
suggesting that moderately elevated CAN levels do not 
disrupt nucleocytoplasmic transport [33]. Finally, it can­
not be absolutely excluded that even mild overexpression 
of CAN induces an artificial localization of the protein at 
the nuclear side of the NPC, without any relevance to 
the mechanism of nucleocytoplasmic trafficking. How­
ever, the specificity of the localization of overexpressed 
CAN protein is striking: CAN is exclusively detected at 
the NPCs, and not in any other cellular compartment or 
structure. This argues that CAN has the ability to bind
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FIG. 1 . CAN localizes to both sides of the NPCs of CAN-overexpressing CE490S cells. Ultrathin cryosections were immunolabeled with 
polyclonal aCNN antiserum, followed by 10-nm gold-conjugated protein A. Selected examples of labeled NPC cross sections are aligned 
with their cytoplasmic and nucleoplasmic sides up and down, respectively. The NPCs are indicated (np). (A) Localization of epitopes of N- 
terminal CAN at both the cytoplasmic and the nucleoplasmic sides of the NPC. (B) Gold decorating the nucleoplasmic side of the NPC. 
Magnification is 120,000 times.
specifically to nucleoplasmic components of the nuclear 
pore complex, in addition to its established association 
with the cytoplasmic fibrils, and that mildly overex­
pressing cells could very well reinforce a normal biological 
situation.
Repeat-containing NPC proteins, such as CAN, are 
believed to play an important role in transport across 
the NPC, but the precise function of the repeats in this 
process is unknown [4,5]. To date, in vitro studies have 
shown that FG peptide motifs may serve as binding 
sites along the pore for specific factors carrying trans­
port substrates [18,19, 33, 34]. Each NPC protein that 
has been localized to a specific subregion of the NPC, 
with the exception of p62, is confined to a specific niche 
either on the cytoplasmic or the nucleoplasmic side. 
Immunoelectron microscopy has demonstrated that 
RanBP2/Nup358 localizes to the cytoplasmic fibrils [21,
22, 35-37], whereas Nupl53 and Nup98 are constit­
uents of the nuclear basket [18, 22, 38, 39]. These find­
ings have provided the basis for several transport mod­
els in which FG-repeat-containing nucleoporins form a 
static array of docking sites that transiently interact 
with transport complexes [8, 9, 15].
Based on our subcellular localization data it appears 
that CAN could interact with transport complexes at 
both sides of the NPC. CAN depletion in mouse em­
bryos results in defects in both nuclear protein import 
and mRNA export. Therefore, a symmetric distribution 
of CAN may be important for bidirectional transport 
of different substrates through the nuclear pore. Like
CAN, other nucleoporins could also localize to multiple 
sites within the NPC. In this respect, it is interesting 
that Cordes et al. [39] found a small but significant 
amount of Nupl53 at the cytoplasmic side of the NPC 
of mouse liver cells and Xenopus nuclei that was not 
detected in studies where harsher fixation conditions 
were used. Alternatively, the presence of CAN at the 
cytoplasmic and nucleoplasmic fibrils could reflect 
CAN’s ability to move through the pore with the trans­
port complex.
It will be interesting to assess whether overex­
pressing other NPC proteins affects their sublocaliza­
tion. The finding that some nucleoporins are present 
in different subregions of the NPC at distinct concen­
trations may be relevant to our understanding of the 
role of nucleoporins in nucleocytoplasmic transport.
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